Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.6M Sell
56,265
-302
-0.5% -$123K 0.04% 362
2025
Q4
$17.7M Buy
56,567
+44,355
+363% +$14.1M 0.02% 486
2025
Q3
$3.3M Buy
12,212
+270
+2% +$61.9K ﹤0.01% 1139
2025
Q2
$2.63M Buy
11,942
+210
+2% +$37.8K ﹤0.01% 1178
2025
Q1
$1.54M Buy
11,732
+1,819
+18% +$254K ﹤0.01% 1384
2024
Q4
$1.36M Sell
9,913
-665
-6% -$91.4K ﹤0.01% 1445
2024
Q3
$1.07M Sell
10,578
-559
-5% -$44.2K ﹤0.01% 1549
2024
Q2
$815K Buy
11,137
+454
+4% +$29.8K ﹤0.01% 1655
2024
Q1
$540K Buy
10,683
+5,409
+103% +$254K ﹤0.01% 1967
2023
Q4
$247K Buy
+5,274
New +$240K ﹤0.01% 2509

Other funds holding AGX

Mariner's AGX Position: Q1 2026 in Review

Mariner reduced its Argan (AGX) stake by 0.53% in Q1 2026, selling an estimated $123K and leaving 56,265 shares worth $30.6M. The position accounts for 0.04% of the portfolio, ranked #362.

Mariner first reported a position in AGX in Q4 2023 and has held it in 10 quarters since. 495 funds tracked by Wall St. Rank hold AGX as of Q1 2026.

  • Mariner held 56,265 shares of Argan worth $30.6M as of Q1 2026.
  • Mariner sold 302 Argan shares in Q1 2026, an estimated $123K.
  • Argan made up 0.04% of Mariner's portfolio in Q1 2026, its #362 holding.
  • Mariner first reported a position in Argan in Q4 2023 and has held it in 10 quarters since.
  • 495 funds tracked by Wall St. Rank held Argan as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.